Stanford University
Showing 551-560 of 2,546 Results
-
Bomi Lee
Assistant Professor of Pediatrics (Gastroenterology, Hepatology, and Nutrition)
Current Research and Scholarly InterestsMy lab is dedicated to unraveling the complexities of the immune microenvironment and its role in the pathogenesis of pancreatic diseases, such as pancreatitis and pancreatic cancer. By leveraging cutting-edge technology, innovative experimental and genetic animal models, as well as human specimens from donors, we aim to identify novel immune markers and potential therapeutic targets. Our goal is to advance the understanding of immune cells and their contributions to these diseases and to transl
-
Byrne Lee, MD FACS
Clinical Professor, Surgery - General Surgery
BioDr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.
Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.
Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries.
